Clinical Trials Logo

Other Heavy-For-Dates Infants clinical trials

View clinical trials related to Other Heavy-For-Dates Infants.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04315545 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Pregnancy Outcomes and Maternal Insulin Sensitivity

PROMIS
Start date: February 6, 2020
Phase:
Study type: Observational [Patient Registry]

The PROMIS study will focus on maternal insulin sensitivity thourghout pregnancy and postpartum in a moderate to high risk population (BMI ≥25 kg/m2) in developing adverse pregnancy outcomes. Next to the OGTT, the meal tolerance test (MTT) will be used as a tool for metabolic testing. The investigators hypothesize that (early) pregnancy assessment of maternal glucose-insulin metabolism with a MTT in a moderate to high risk group identify more mothers at risk for adverse pregnancy outcomes compared with standard OGTT testing at 24-28 weeks.